• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-17-92簇与膀胱癌肌肉浸润的相关性

Association of miRNA-17-92 Cluster with Muscle Invasion in Bladder Cancer.

作者信息

Pavalean Mihai Ioan, Dobre Maria, Pelisenco Iulia Andreea, Madan Victor Lucian, Milanesi Elena, Hinescu Mihail Eugen

机构信息

Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Emergency University Central Military Hospital, 010825 Bucharest, Romania.

出版信息

Int J Mol Sci. 2025 Aug 5;26(15):7546. doi: 10.3390/ijms26157546.

DOI:10.3390/ijms26157546
PMID:40806674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12347747/
Abstract

Bladder cancer (BC) is the most frequent cancer of the urinary system and one of the most common malignancies in the world. In the last decade, many studies have been conducted to better understand the pathophysiological mechanisms of BC to find innovative markers for disease monitoring and treatment. In this study, we aim to identify miRNAs whose expression is associated with specific tumoral characteristics and risks of disease progression. Forty-one BC patients were enrolled in this study. The expression of 84 miRNAs was evaluated by qRT-PCR analysis on tumoral and peritumoral tissues. The results highlighted the association of the miRNA-17-92 cluster with BC, with miR-17-5p, miR-18a-5p, miR-19a-3p, and miR-20a-5p (members of this cluster) being upregulated in the tumoral tissue and correlated with muscle invasion and tumor grading. Taken together, our study identified a panel of 26 dysregulated miRNAs in BC, some of which may be associated with aggressiveness and the risk of progression of this malignancy.

摘要

膀胱癌(BC)是泌尿系统最常见的癌症,也是全球最常见的恶性肿瘤之一。在过去十年中,人们进行了许多研究,以更好地了解膀胱癌的病理生理机制,寻找用于疾病监测和治疗的创新标志物。在本研究中,我们旨在鉴定其表达与特定肿瘤特征和疾病进展风险相关的微小RNA(miRNA)。本研究纳入了41例膀胱癌患者。通过对肿瘤组织和瘤旁组织进行定量逆转录聚合酶链反应(qRT-PCR)分析,评估了84种miRNA的表达。结果突出显示了miRNA-17-92簇与膀胱癌的关联,该簇成员miR-17-5p、miR-18a-5p、miR-19a-3p和miR-20a-5p在肿瘤组织中上调,并与肌肉浸润和肿瘤分级相关。综上所述,我们的研究鉴定出了一组在膀胱癌中失调的26种miRNA,其中一些可能与这种恶性肿瘤的侵袭性和进展风险相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ccd/12347747/a2ca5dc18411/ijms-26-07546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ccd/12347747/7dd3755eb174/ijms-26-07546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ccd/12347747/e2d9d9c3c0e0/ijms-26-07546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ccd/12347747/a2ca5dc18411/ijms-26-07546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ccd/12347747/7dd3755eb174/ijms-26-07546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ccd/12347747/e2d9d9c3c0e0/ijms-26-07546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ccd/12347747/a2ca5dc18411/ijms-26-07546-g003.jpg

相似文献

1
Association of miRNA-17-92 Cluster with Muscle Invasion in Bladder Cancer.miRNA-17-92簇与膀胱癌肌肉浸润的相关性
Int J Mol Sci. 2025 Aug 5;26(15):7546. doi: 10.3390/ijms26157546.
2
MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.肿瘤样本和尿液细胞外囊泡中的 microRNAs 作为肌肉浸润性膀胱癌的一种潜在诊断工具。
J Cancer Res Clin Oncol. 2019 Nov;145(11):2725-2736. doi: 10.1007/s00432-019-03035-6. Epub 2019 Sep 24.
3
MiR-20a-5p Inhibits Bladder Cancer Proliferation and Migration by Targeting KPNA2.微小RNA-20a-5p通过靶向核转运蛋白α2抑制膀胱癌的增殖和迁移。
J Cell Mol Med. 2025 Aug;29(16):e70785. doi: 10.1111/jcmm.70785.
4
CENPF overexpression in bladder cancer cells enhances proliferation, migration, invasion, and apoptosis.膀胱癌细胞中CENPF的过表达增强了细胞的增殖、迁移、侵袭和凋亡。
Sci Rep. 2025 Jul 14;15(1):25398. doi: 10.1038/s41598-025-10677-9.
5
Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.沉默环状 RNA VANGL1 通过调控 miR-1184/IGFBP2 轴抑制膀胱癌的进展。
Cancer Med. 2020 Jan;9(2):700-710. doi: 10.1002/cam4.2650. Epub 2019 Nov 23.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by Analysis of Differential Gene Expression.揭示血清 miR-483-5p 的潜力:通过差异基因表达分析,作为 OLp 和 OSCC 患者的有前途的诊断和预后生物标志物。
Curr Pharm Des. 2024;30(4):310-322. doi: 10.2174/0113816128276149240108163407.
8
MiR-101-3p and miR-106b-5p roles in EMT pathway: prognostic and therapeutic insights for luminal breast cancer.MiR-101-3p和miR-106b-5p在EMT途径中的作用:腔面型乳腺癌的预后和治疗见解
J Egypt Natl Canc Inst. 2025 Jul 21;37(1):43. doi: 10.1186/s43046-025-00304-z.
9
The novel ferroptosis-inducing molecule can inhibit the progression of BC by regulating the ubiquitination of UHRF1.这种新型的铁死亡诱导分子可通过调节UHRF1的泛素化来抑制乳腺癌的进展。
Epigenomics. 2025 Jul 16:1-15. doi: 10.1080/17501911.2025.2530923.
10
Long non-coding RNA MINCR silencing contributes to suppressed gemcitabine resistance in bladder cancer by blocking the ZEB1/PHGDH axis through microRNA-876-5p up-regulation.长链非编码RNA MINCR沉默通过上调微小RNA-876-5p阻断ZEB1/PHGDH轴,从而有助于抑制膀胱癌对吉西他滨的耐药性。
J Mol Histol. 2025 Jul 9;56(4):220. doi: 10.1007/s10735-025-10510-7.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer.miRNAs 在膀胱癌进展、分层和预测相关临床结局中的作用。
Int J Mol Sci. 2024 Feb 11;25(4):2178. doi: 10.3390/ijms25042178.
3
Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment.
尿液外泌体miR-17-5p通过抑制其靶基因ARID4B和调节免疫微环境促进膀胱癌侵袭。
Clin Genitourin Cancer. 2024 Apr;22(2):569-579.e1. doi: 10.1016/j.clgc.2024.01.012. Epub 2024 Jan 22.
4
Detecting Muscle Invasion of Bladder Cancer: An Application of Diffusion Kurtosis Imaging Ratio and Vesical Imaging-Reporting and Data System.检测膀胱癌的肌肉侵犯:扩散峰度成像比值和膀胱影像报告和数据系统的应用。
J Magn Reson Imaging. 2024 Jul;60(1):54-64. doi: 10.1002/jmri.29053. Epub 2023 Nov 2.
5
Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs.中高危非肌层浸润性膀胱癌:流行病学、疾病负担及未满足需求概述
Front Oncol. 2023 Jun 2;13:1170124. doi: 10.3389/fonc.2023.1170124. eCollection 2023.
6
LncRNA GAS5 regulates the Wnt/β-catenin pathway through the miR-18a-5p/AXIN2/GSK3β axis to inhibit the proliferation and migration of bladder cancer cells.长链非编码 RNA GAS5 通过 miR-18a-5p/AXIN2/GSK3β 轴调控 Wnt/β-catenin 通路抑制膀胱癌细胞的增殖和迁移。
Carcinogenesis. 2022 Dec 31;43(12):1176-1189. doi: 10.1093/carcin/bgac087.
7
The miR-17-92 cluster: Yin and Yang in human cancers.miR-17-92簇:人类癌症中的阴阳
Cancer Treat Res Commun. 2022;33:100647. doi: 10.1016/j.ctarc.2022.100647. Epub 2022 Oct 14.
8
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer.高表达 miR-17-5p 和 miR-20a-5p 可预测 I-III 期结肠癌的有利疾病特异性生存。
Sci Rep. 2022 Apr 30;12(1):7080. doi: 10.1038/s41598-022-11090-2.
9
MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.膀胱癌患者生存时间估计的 microRNA 特征。
Sci Rep. 2022 Mar 9;12(1):4141. doi: 10.1038/s41598-022-08082-7.
10
Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis.血清miR-17-92簇作为膀胱癌诊断的非侵入性生物标志物的评估
Front Oncol. 2021 Dec 22;11:795837. doi: 10.3389/fonc.2021.795837. eCollection 2021.